Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Long-acting insulin analogs versus human insulins.

Garg SK, Naik RG.

Diabetes Technol Ther. 2008 Oct;10(5):331-2. doi: 10.1089/dia.2008.0071. No abstract available.

PMID:
18715208
2.

Insulin analogs versus human insulin in type 2 diabetes.

Migdalis IN.

Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S102-4. doi: 10.1016/S0168-8227(11)70023-7. Review.

PMID:
21864739
3.

Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.

Owens DR, Bolli GB.

Diabetes Technol Ther. 2008 Oct;10(5):333-49. doi: 10.1089/dia.2008.0023. Review.

PMID:
18715209
4.

Newer insulins in type 2 diabetes.

Gale EA.

BMJ. 2012 Sep 11;345:e4611. doi: 10.1136/bmj.e4611. Review. No abstract available.

PMID:
22968720
5.

Advances in basal insulin therapy: lessons from current evidence.

Singh AK, Sinha B.

J Indian Med Assoc. 2013 Nov;111(11):735-6, 738-42. Review. No abstract available.

PMID:
24968481
6.

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613. Review.

PMID:
17443605
7.

Insulin detemir in the treatment of type 1 and type 2 diabetes.

Philips JC, Scheen A.

Vasc Health Risk Manag. 2006;2(3):277-83. Review.

8.

The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review.

Garg SK.

Diabetes Technol Ther. 2010 Jan;12(1):11-24. doi: 10.1089/dia.2009.0127. Review.

PMID:
20082581
9.

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.

Frier BM, Russell-Jones D, Heise T.

Diabetes Obes Metab. 2013 Nov;15(11):978-86. doi: 10.1111/dom.12106. Epub 2013 May 1. Review.

PMID:
23551900
10.

Insulin glargine in a Brazilian state: should the government disinvest? An assessment based on a systematic review.

Caires de Souza AL, de Assis Acurcio F, Guerra JĂșnior AA, Rezende Macedo do Nascimento RC, Godman B, Diniz LM.

Appl Health Econ Health Policy. 2014 Feb;12(1):19-32. doi: 10.1007/s40258-013-0073-6. Review.

PMID:
24385261
11.

Insulin Glargine: a review 8 years after its introduction.

Goykhman S, Drincic A, Desmangles JC, Rendell M.

Expert Opin Pharmacother. 2009 Mar;10(4):705-18. doi: 10.1517/14656560902775677 . Review.

PMID:
19284367
12.

Newer basal insulin analogues: degludec, detemir, glargine.

Kalra S.

J Pak Med Assoc. 2013 Nov;63(11):1442-4. Review. No abstract available.

13.

The use of insulin analogues in pregnancy.

Lambert K, Holt RI.

Diabetes Obes Metab. 2013 Oct;15(10):888-900. doi: 10.1111/dom.12098. Epub 2013 Apr 9. Review.

PMID:
23489521
14.

Insulin glargine versus NPH insulin in patients with type 1 diabetes.

Ratner R.

Drugs Today (Barc). 2003 Nov;39(11):867-76. Review.

PMID:
14702132
15.

Cost-effectiveness of insulin detemir: a systematic review.

Suh DC, Aagren M.

Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):641-55. doi: 10.1586/erp.11.73. Epub 2011 Oct 3. Review.

PMID:
21961796
16.

Basal insulin analogs: from pathophysiology to therapy. What we see, know, and try to comprehend?

Monnier L, Colette C, Owens D.

Diabetes Metab. 2013 Dec;39(6):468-76. doi: 10.1016/j.diabet.2013.09.003. Epub 2013 Oct 17. Review.

PMID:
24139826
17.

Insulin analogues: new dimension of management of diabetes mellitus.

Siddiqui NI.

Mymensingh Med J. 2007 Jan;16(1):117-21. Review.

PMID:
17344794
19.

Basal insulins: Pharmacological properties and patient perspectives.

Abrahamson MJ.

Prim Care Diabetes. 2010 Apr;4 Suppl 1:S19-23. doi: 10.1016/S1751-9918(10)60005-8. Review.

PMID:
20394887
20.

Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.

Dunn CJ, Plosker GL.

Pharmacoeconomics. 2002;20(14):989-1025. Review.

PMID:
12403639

Supplemental Content

Support Center